共 50 条
- [41] Pathogenetic role of germline and somatic DDX41 mutations in the pathogenesis of myeloid malignanciesCANCER SCIENCE, 2024, 115 : 1685 - 1685Kon, AyanaNakagawa, MasahiroKataoka, KeisukeMori, TakutoKakiuchi, NobuyukiMakishima, HidekiOchi, YotaroNakayama, ManabuKoseki, HaruhikoNannya, YasuhitoOgawa, Seishi
- [42] Germ line DDX41 mutations define a unique subtype of myeloid neoplasms (vol 141, pg 534, 2023)BLOOD, 2024, 143 (18) : 1879 - 1879Makishima, H.Saiki, R.Nannya, Y.
- [43] The functional role of compound DDX41 germline and somatic R525H mutations in the development of myeloid neoplasmsCANCER SCIENCE, 2021, 112 : 454 - 454Kon, AyanaNakagawa, MasahiroInagaki, RyosakuKataoka, KeisukeOchi, YotaroMakishima, HidekiNakayama, ManabuKoseki, HaruhikoNannya, YasuhitoOgawa, Seishi
- [44] Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variantsAMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (11) : 1780 - 1790Bataller, AlexLoghavi, SanamGerstein, YohevedBazinet, AlexandreSasaki, KojiChien, Kelly S.Hammond, DanielleMontalban-Bravo, GuillermoBorthakur, GautamShort, NicholasIssa, Ghayas C.Kadia, Tapan M.Daver, NavalTang, GuilinQuesada, AndresPatel, Keyur P.Ravandi, FarhadFiskus, WarrenMill, Cristopher P.Kantarjian, Hagop M.Bhalla, KapilGarcia-Manero, GuillermoOran, BetulDinardo, Courtney D.
- [45] Lifting the veil on germline DDX41 mutationsBLOOD, 2019, 134 (17) : 1368 - 1370Sanders, Mathijs A.
- [46] Investigating the role of the somatic DDX41 variant in the context of DDX41 hereditary myeloid malignancy syndromes (HMMS)CANCER RESEARCH, 2024, 84 (03)Marando, LudovicaBadar, TalhaKusne, YaelMorris, AudreyLasho, TerraMangaonkar, AbhishekFinke, ChristyCrawley, CarlesForan, James M.Al-Kali, ArefKing, AndrewAlkhateeb, HassanGangat, NaseemaWong, ChiHe, RongViswanatha, DavidBasheer, FaisalLitzow, MarkFerrer, AlejandroVassiliou, GeorgePatnaik, Mrinal
- [47] DDX41: germline mutation and predisposition to myeloid hemopathiesHEMATOLOGIE, 2022, 28 (02): : 106 - 107Bories, D.
- [48] DDX41 Mutations in Myeloid Neoplasms Are Associated with Male Predominance, TP53 mutation and a High Risk of Progression to AMLMODERN PATHOLOGY, 2018, 31 : 545 - 545Quesada, Andres E.DiNardo, CourtneyRoutbort, MarkBueso-Ramos, CarlosKanagal-Shamanna, RashmiZuo, ZhuangYin, C. CameronLoghavi, SanamOk, Chi YoungWang, SaBenton, ChristopherKantarjian, Hagop M.Luthra, RajyalakshmiMedeiros, L. JeffreyPatel, Keyur
- [49] DDX41 Mutations in Myeloid Neoplasms Are Associated with Male Predominance, TP53 mutation and a High Risk of Progression to AMLLABORATORY INVESTIGATION, 2018, 98 : 545 - 545Quesada, Andres E.DiNardo, CourtneyRoutbort, MarkBueso-Ramos, CarlosKanagal-Shamanna, RashmiZuo, ZhuangYin, C. CameronLoghavi, SanamOk, Chi YoungWang, SaBenton, ChristopherKantarjian, Hagop M.Luthra, RajyalakshmiMedeiros, L. JeffreyPatel, Keyur
- [50] Clinical Characteristics and Prognosis of Thirty-Three Patients with Myeloid Neoplasms and DDX41 Mutation: Mayo Clinic ExperienceBLOOD, 2021, 138 : 3691 - +Nanaa, AhmadAl-Kali, ArefViswanatha, David S.Foran, James M.Badar, TalhaSproat, Lisa Z.He, RongNguyen, Phuong L.Jevremovic, DraganSalama, Mohamed E.Greipp, PatriciaGangat, NaseemaTefferi, AyalewLitzow, Mark R.Mangaonkar, Abhishek A.Shah, Mithun V.Patnaik, Mrinal M.Alkhateeb, Hassan B.